Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine IR vs sublingual buprenorphine as add-on to transdermal buprenorphine in chronic low back pain
2004-002311-91Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of buprenorphine in chronic low back pain (CLBP) and lumbodynia (LBP) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Efficacy. Started Dec 2005; status: completed.
02
Drugs
buprenorphine
03
Conditions
chronic low back pain (CLBP)lumbodynia (LBP)
Beyond the preview
Go deeper on 2004-002311-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002311-91.